The aim of the study was to evaluate whether the combination of ketanserin with captopril
exerts an additive antihypertensive effect, as compared with single drug treatment. Twelve …

17 subjects with essential hypertension (14 male, 3 female-ages: 40–69 years), 13 of whom
continued their previous anti-hypertensive therapy, completed a double-blind cross-over trial …

The long-term safety and efficacy of ketanserin in the treatment of essential hypertension
was assessed in monotherapy or in combination with the beta-blocker, metoprolol. In an …

Seventeen subjects with essential hypertension (14 men, 3 women, 40-69 years of age), 13
of whom continued their previous antihypertensive therapy, completed a double-blind …

Two double-blind multicenter trials were performed to compare the antihy pertensive action
of ketanserin, at an oral dosage of 20 mg three times daily, with that of placebo over a period …

Sixty patients, with mild to moderate essential hypertension, were considered for a double-
blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group …

Monotherapy with Ketanserin, a serotonin receptor antagonist, reduces blood pressure in a
sizeable number of patients with essential hypertension. The present study was designed to …

The antihypertensive effect of ketanserin in combination with [beta]-adrenergic blockade
was assessed in a double-blind crossover (4 weeks) manner in 10 patients with essential …

In the Swiss Ketanserin Study the antihypertensive efficacy and tolerability of ketanserin
(given in 20 or 40 mg doses twice daily) was investigated, after a placebo run-in phase, as …

The effects of monotherapy with once-daily ketanserin (40 mg) were compared to those of
ketanserin (40 mg) plus hydrochlorothiazide (25 mg) once daily in 21 patients with mild …